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Success of the nstional health education prowm. The 
Fourth Joint National Committee (INC.IV) report on the 
detection, evaluation and treatment of high blood pressure 
has just been released by the National High Blood Pressure 
Education Program (I). This fourth report marks a historic 
landmark-15 years of coordinated programs shared by 32 
professional health care organizations that comprise the 
ongoing advisory Coordinating Committee to the program. 
That these many organizedons have come together over this 
I5 year period to periodicaliy assess and agree on ways to 
detect, evaluate and treat hypertension is truly remarkable. 
Over these years. each participated with the coonnon egree- 
ment of using the cottsensus process to interpret and trans. 
late into everyday medical practice the significance of ad- 
vences in the laboratory and in chnical invest~gaioo. 
This ongoing success is what bar driven this program. As 
e result, more Americans are awere of their blood pressure 
and know whether they have hypertension; they are more 
likely to visit a physician and to be treated for this disorder 
and they are more likely to have their blood pressure under 
control today than they were IS yews ego (can we remember 
the often quoted “one-half of one-half of one-half’ stete- 
meet that indicated that only 12% of people with hypenen- 
sion were under adequate conrrol?). More importantly, 
stroke mortality has decreased by 50% since this national 
program began. This decline in stroke mortality can be 
attributed to the increased number of patients receiving 
antihypertensive therapy. Associated with this decline in 
stroke mortality i< a 35% reduction in deaths from myocer- 
dial infarction. No doubt this can be ascribed. in pan, to 
control of hypertensive disease, one of the more common of 
the major treatable risk factors underlying typical heart 
disease. Although other major advances have taken place in 
this regard (such as reduction in cigarette smoking, im- 
proved dietary and other “wellness” practices, establish- 
ment of coronary care units and the like), the National High 
Blood Pressure Education Program has been our outstanding 
s”cCeEE. 
After dl, it wes the success of this unique and pioneering 
national health education program that was jointly spon- 
sored by the National Institutes of Health, the health care 
professions and the public that gave confidence to the 
National Heart, Lung. and Blood Institute to move ahead 
into new areas of health education. Tbe control of blood 
pressure ana the national wareoes~ of the major problem of 
hypertension provided the impetus for the establishment of 
the recent National High Cholesterol Education Program. 
Indeed. over these 15 years. the rate of increase in the 
number of patient visits for hypertension surpassed patient 
visits for all medical reasons and resulted in remarkable 
achievements in public health. A new era of “preventive 
cardiology” came of age. 
What is oew about the 1988 JNC-IV report? Af7er all that 
has been written and said about hypertension in the iast two 
decades, what can be so different about this new 1988 Joint 
Nat;onal Committee report? The wcalkd stepped-care pro- 
cess, which brought reason and order to the treatment of 
hypertension in the 1970s. has oow evolved to Permit 
inclusion of the newer pharmacologic advances. Thus, 
stepped care has been modified to consider the individual 
patient’s characteristics as they relate to drug actions. To- 
day’s physician has so much more to offer patients with 
hypertension that control of this disease can be more effec- 
tive and specific, with fewer side elTects. The aooroeeh to 
management has been changed so that adverse kffects of 
treatment are minimized and adherence to therapy is facili- 
tated. 
The new JNC-IV report also deals with special groups 
and special complications of hypertension such as diabetes 
mellitus, renovascular disease, hypertension in elderly pa- 
tients and children and hypertension complicating cardiovas- 
cular problems. Each of these situations requires a special 
approach and the new report provides important guidelines. 
It also reviews data from a v&iety of recent cii&al trials. 
These clinical hypertension trials have dctnoosrrated the 
continued &icacy of treatment and the need for more 
aggressive management of this disease, especially in the 
presence of other cardiovascular risk factors. Nonpherma- 
cologic therapy continues to be a useful component in the 
overall management of the hypertensive patient. and 
changes have been incorporated based on tbc most recent 
epidemiologic data. For example. for t.hose who imbibe, the 
report recommends that the level of alcohol consumption be 
reduced by one-half from that suggested in previous Joint 
National Committee reports. 
Finally, hard work under a short lime constraint by the 
fidented men and women of this commirree should be 
acknowledged. When the available ewdencc was not as good 
as it could be, their personal clinical and scientific impres- 
sions were also brought to bear on assessment of the best 
approach for practicing physicians to manage hypertension. 
It was clear that there was a sincere desire to&c sound 
advice whenever possible in the face of rhe!ack ofdataon PO 
many points (which must await additmnal evidence from 
clinal trialsl. As with its predecessors. rhk report Fhoutd 
wve a% a guide to health care providen in managing an 
important public health problem. It was this quality that led 
to the new gutdelines in managing tbe hyperlipidemias. The 
new repon sboutd help physicians to control hypertension in 
[heir patients and to continue the splendid decline iil d&x. 
from stroke and coronary heart disease. 
